Camlin Fine Sciences Limited (BOM: 532834)

Market Cap	19.32B
Revenue (ttm)	16.06B
Net Income (ttm)	-2.23B
Shares Out	167.50M
EPS (ttm)	-13.38
PE Ratio	n/a
Forward PE	36.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,596
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	80.00 - 143.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Camlin Fine Sciences

Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include antioxidants comprises Butylated Hydroxy Toluene and Ascorbyl palmitate; and emulsifiers, mold inhibitors, antibacterial agents, toxin binders, pellet binders, disinfectants, energizers, preservatives, thickening agents, and growth promoters, as well as plant-based antioxi...

• Industry: Chemicals and Allied Products
• Founded: 1931
• Employees: 624
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532834